These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2898480

  • 1. Effects of hypoxia and adrenergic stimulation induced alterations in PGI2 synthesis by diabetic coronary arteries.
    Koltai MZ, Rösen P, Hadházy P, Ballagi-Pordány G, Köszeghy A, Pogátsa G.
    J Diabet Complications; 1988; 2(1):5-7. PubMed ID: 2898480
    [Abstract] [Full Text] [Related]

  • 2. Relationship between vascular adrenergic receptors and prostaglandin biosyntheses in canine diabetic coronary arteries.
    Koltai MZ, Rösen P, Hadházy P, Ballagi-Pordány G, Köszeghy A, Pogátsa G.
    Diabetologia; 1988 Sep; 31(9):681-6. PubMed ID: 2853089
    [Abstract] [Full Text] [Related]

  • 3. Role of vascular adrenergic mechanisms in the haemodynamic and PGI2 stimulating effects of angiotensin in diabetic dogs.
    Koltai MZ, Pósa I, Kocsis E, Rösen P, Pogátsa G.
    Mol Cell Biochem; 1996 Sep; 163-164():151-7. PubMed ID: 8974051
    [Abstract] [Full Text] [Related]

  • 4. Disturbed lipid metabolism in diabetic coronary vessels.
    Koltai MZ, Rösen P, Hadházy P, Aranyi Z, Ballagi-Pordány G, Pogátsa G.
    Mol Cell Biochem; 1992 Feb 12; 109(2):189-96. PubMed ID: 1320734
    [Abstract] [Full Text] [Related]

  • 5. Contractile activity and prostacyclin generation in isolated coronary arteries from diabetic dogs.
    Sterin-Borda L, Borda ES, Gimeno MF, Lazzari MA, del Castillo E, Gimeno AL.
    Diabetologia; 1982 Jan 12; 22(1):56-9. PubMed ID: 7037509
    [Abstract] [Full Text] [Related]

  • 6. Increased vasoconstrictor response to noradrenaline in femoral vascular bed of diabetic dogs. Is thromboxane A2 involved?
    Koltai MZ, Rösen P, Ballagi-Pordány G, Hadházy P, Pogátsa G.
    Cardiovasc Res; 1990 Sep 12; 24(9):707-10. PubMed ID: 2121358
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia-induced release of prostaglandins: mechanisms and sources of production in coronary resistance vessels of the isolated rabbit heart.
    Nakhostine N, Laurent CE, Nadeau R, Cardinal R, Lamontagne D.
    Can J Physiol Pharmacol; 1995 Dec 12; 73(12):1742-9. PubMed ID: 8834488
    [Abstract] [Full Text] [Related]

  • 8. Augmented thromboxane generation by mesenteric arteries from pancreatectomized diabetic dogs is coincident with the vascular tone enhancement evoked by Na arachidonate and prostacyclin.
    Sterin-Borda L, Franchi AM, Borda ES, Del Castillo E, Gimeno MF, Gimeno AL.
    Eur J Pharmacol; 1984 Aug 17; 103(3-4):211-21. PubMed ID: 6436040
    [Abstract] [Full Text] [Related]

  • 9. Diminished vasodilation; imbalance of synthesized cyclooxygenase products by adrenergic mediation in diabetic coronaries of the dog.
    Koltai MZ, Rösen P, Pogátsa G.
    Prog Clin Biol Res; 1989 Aug 17; 301():449-53. PubMed ID: 2508113
    [No Abstract] [Full Text] [Related]

  • 10. Prostacyclin (PGI2) and U-46619 stimulate coronary arteries from diabetic dogs and their action is influenced by inhibitors of prostaglandin biosynthesis.
    Sterin-Borda L, Gimeno M, Borda E, del Castillo E, Gimeno AL.
    Prostaglandins; 1981 Aug 17; 22(2):267-78. PubMed ID: 7027326
    [Abstract] [Full Text] [Related]

  • 11. Differential changes of adrenoceptor- and muscarinic receptor-linked prostacyclin synthesis by the aorta and urinary bladder of the diabetic rat.
    Jeremy JY, Thompson CS, Mikhailidis DP.
    Br J Pharmacol; 1993 Apr 17; 108(4):1131-6. PubMed ID: 8485622
    [Abstract] [Full Text] [Related]

  • 12. Prejunctional and postjunctional actions of endogenous norepinephrine at the sympathetic neuroeffector junction in canine coronary arteries.
    Cohen RA, Shepherd JT, Vanhoutte PM.
    Circ Res; 1983 Jan 17; 52(1):16-25. PubMed ID: 6129074
    [Abstract] [Full Text] [Related]

  • 13. Effects of aldose reductase inhibitors on prostacyclin (PGI2) synthesis by aortic rings from rats with streptozotocin-induced diabetes.
    Wakasugi M, Noguchi T, Inoue M, Tawata M, Shindo H, Onaya T.
    Prostaglandins Leukot Essent Fatty Acids; 1991 Dec 17; 44(4):233-6. PubMed ID: 1840007
    [Abstract] [Full Text] [Related]

  • 14. Effects of cyclooxygenase inhibitors, prostaglandins F2 alpha and I2, on isolated coeliac and basilar arteries of alloxan-diabetic dogs.
    Koltai MZ, Hadházy P, Malomvölgyi B, Wagner M, Pogátsa G.
    Eur J Clin Invest; 1984 Apr 17; 14(2):130-4. PubMed ID: 6428901
    [Abstract] [Full Text] [Related]

  • 15. Vascular prostacyclin release and metabolic derangement in diabetes.
    Harrison HE, Johnson M.
    Horm Metab Res Suppl; 1981 Apr 17; 11():43-9. PubMed ID: 7033096
    [Abstract] [Full Text] [Related]

  • 16. Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus.
    Setty S, Sun W, Martinez R, Downey HF, Tune JD.
    J Appl Physiol (1985); 2004 Jul 17; 97(1):431-8. PubMed ID: 14978008
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of diabetic rat aorta to self-deactivation during prostacyclin synthesis.
    Kawamura K, Dohi T, Ogawa T, Shirakawa M, Okamoto H, Tsujimoto A.
    Prostaglandins Leukot Med; 1987 Jun 17; 28(1):1-13. PubMed ID: 3112803
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.